Carolina Wealth Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-8,508
| Closed | -$64K | – | 305 |
|
|
2022
Q2 | $64K | Buy |
8,508
+560
| +7% | +$4.21K | 0.04% | 109 |
|
|
2022
Q1 | $75K | Buy |
7,948
+405
| +5% | +$3.82K | 0.05% | 106 |
|
|
2021
Q4 | $60K | Buy |
7,543
+174
| +2% | +$1.38K | 0.03% | 131 |
|
|
2021
Q3 | $72K | Sell |
7,369
-72
| -1% | -$703 | 0.05% | 115 |
|
|
2021
Q2 | $74K | Buy |
7,441
+1,161
| +18% | +$11.5K | 0.05% | 121 |
|
|
2021
Q1 | $72K | Buy |
6,280
+6,233
| +13,262% | +$71.5K | 0.05% | 110 |
|
|
2020
Q4 | $0 | Hold |
47
| – | – | ﹤0.01% | 260 |
|
|
2020
Q3 | $0 | Hold |
47
| – | – | ﹤0.01% | 228 |
|
|
2020
Q2 | $1K | Hold |
47
| – | – | ﹤0.01% | 163 |
|
|
2020
Q1 | $0 | Hold |
47
| – | – | ﹤0.01% | 204 |
|
|
2019
Q4 | $0 | Buy |
+47
| New | – | ﹤0.01% | 186 |
|